Apheresis is a process wherein blood is collected and
separated into different components, leveraging on centrifugation and membrane
separation technology.
MarketsandMarkets recently conducted a study on the “Apheresis
Market - Applications (Plasmapheresis, Plateletpheresis,
RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Procedures (Therapeutic
& Donor Apheresis/Automated Blood Component Collection), Devices &
Disposables - Forecasts to 2017”, which analyzed and studied
the major market drivers, restraints, and opportunities in North America,
Europe, Asia, and Rest of the World.
http://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html
Early buyers will receive 10% customization in this report.
Early buyers will receive 10% customization in this report.
The global market is valued at $1,140.8 million in 2012
and is expected to reach $1,922.4 million by 2017, growing at a CAGR of 11%
from 2012 to 2017.
One of the many reasons apheresis is gaining rapid
popularity is due to the fact that it is a “subtractive” therapy which seeks to
restore the blood in nearly its natural state, thereby preserving the body’s
essential functions. Therefore, it can be used to cure intractable diseases as
well as in cases where drug administration should be avoided or minimized, as
in the case of pregnant women, infants, children, and the elderly.
Free PDF Brochure:
The apheresis industry is oligopolistic in nature with a few
large players. The current market leader is Haemonetics Corporation, enjoying
one-third of the market share which is shared between its winning apheresis
devices like Cymbal, MCS+8150, MCS+9000 and PCS 2 and disposables like
Apheresis Solutions, Anticoagulant Citrate Dextrose etc.
A lot is being done to spread awareness and support the
cause of smarter blood management systems like apheresis. Haemonetics, the
global leader in the apheresis market has announced a research grant along with
SABM to support a young researcher planning to study methods of promoting blood
conservation.
By technology, the report has classified the apheresis
market as centrifugation and membrane separation. Centrifugation technology
uses centrifugal force to separate blood components based on their density
whereas membrane separation uses the particle size to separate components. The
former dominates the market.
Enquiry before Buying:
About MarketsandMarkets
MarketsandMarkets is
a global market research and consulting company based in the U.S. We publish
strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets
also provides multi-client reports, company profiles, databases, and custom
research services. M&M covers thirteen industry verticals, including
advanced materials, automotives and transportation, banking and financial
services, biotechnology, chemicals, consumer goods, energy and power, food and
beverages, industrial automation, medical devices, pharmaceuticals,
semiconductor and electronics, and telecommunications and IT.
We at
MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
No comments:
Post a Comment